These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30025978)

  • 21. Long-term quality of life after swallowing and salivary-sparing chemo-intensity modulated radiation therapy in survivors of human papillomavirus-related oropharyngeal cancer.
    Vainshtein JM; Moon DH; Feng FY; Chepeha DB; Eisbruch A; Stenmark MH
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):925-33. PubMed ID: 25832685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Swallowing outcome measures in head and neck cancer--How do they compare?
    Pedersen A; Wilson J; McColl E; Carding P; Patterson J
    Oral Oncol; 2016 Jan; 52():104-8. PubMed ID: 26564310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.
    Bhayani MK; Hutcheson KA; Barringer DA; Lisec A; Alvarez CP; Roberts DB; Lai SY; Lewin JS
    Head Neck; 2013 Nov; 35(11):1634-40. PubMed ID: 23322563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
    JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia.
    Barbon CEA; Peterson CB; Moreno AC; Lai SY; Reddy JP; Sahli A; Martino R; Johnson FM; Fuller CD; Hutcheson KA
    JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):956-964. PubMed ID: 36074459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting swallow outcome following treatment for advanced oral and oropharyngeal malignancies.
    Kalavrezos N; Cotrufo S; Govender R; Rogers P; Pirgousis P; Balasundram S; Lalabekyan B; Liew C
    Head Neck; 2014 Jan; 36(1):47-54. PubMed ID: 23559533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of very late dysphagia after chemoradiation for oropharyngeal squamous cell carcinoma.
    Gharzai LA; Li P; Schipper MJ; Yao J; Mayo CS; Wilkie JR; Hawkins PG; Lyden T; Blakely A; Ibrahim M; Schonewolf CA; Shah J; Eisbruch A; Casper K; Mierzwa M
    Oral Oncol; 2020 Dec; 111():104853. PubMed ID: 32805634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis.
    Aggarwal P; Zaveri JS; Goepfert RP; Shi Q; Du XL; Swartz M; Lai SY; Fuller CD; Lewin JS; Piller LB; Hutcheson KA
    Head Neck; 2019 Nov; 41(11):3880-3894. PubMed ID: 31441572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Office-Based Cricopharyngeus Balloon Dilation for Post Chemoirradiation Dysphagia in Nasopharyngeal Carcinoma Patients: A Pilot Study.
    Fong R; Sun N; Ng YW; Rumbach AF; Ward EC; Tsang R
    Dysphagia; 2019 Aug; 34(4):540-547. PubMed ID: 30888528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study.
    Dragan T; Van Gossum A; Duprez F; Lalami Y; Lefebvre Y; Mootassim-Billah S; Beauvois S; Gulyban A; Vandekerkhove C; Boegner P; Paesmans M; Ameye L; Digonnet A; Quiriny M; Dequanter D; Lipski S; Willemse E; Rodriguez A; Carlot S; Karaca Y; Lemort M; Emonts P; Al Wardi C; Van Gestel D
    Trials; 2022 Dec; 23(1):1036. PubMed ID: 36539781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck.
    Hutcheson KA; Lewin JS; Holsinger FC; Steinhaus G; Lisec A; Barringer DA; Lin HY; Villalobos S; Garden AS; Papadimitrakopoulou V; Kies MS
    Head Neck; 2014 Apr; 36(4):474-80. PubMed ID: 23780650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives.
    Wilson JA; Carding PN; Patterson JM
    Otolaryngol Head Neck Surg; 2011 Nov; 145(5):767-71. PubMed ID: 21746839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6).
    Ringash J; Waldron JN; Siu LL; Martino R; Winquist E; Wright JR; Nabid A; Hay JH; Hammond A; Sultanem K; Hotte S; Leong C; El-Gayed AA; Naz F; Ramchandar K; Owen TE; Montenegro A; O'Sullivan B; Chen BE; Parulekar WR
    Eur J Cancer; 2017 Feb; 72():192-199. PubMed ID: 28040660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer.
    Grant SR; Hutcheson KA; Ye R; Garden AS; Morrison WH; Rosenthal DI; Brandon Gunn G; Fuller CD; Phan J; Reddy JP; Moreno AC; Lewin JS; Sturgis EM; Ferrarotto R; Frank SJ
    Radiother Oncol; 2020 Jul; 148():133-139. PubMed ID: 32361662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.
    Price JM; West CM; Dixon LM; Iyizoba-Ebozue Z; Garcez K; Lee LW; McPartlin A; Slevin F; Sykes A; Prestwich RJD; Thomson DJ
    Radiother Oncol; 2022 Jul; 172():111-117. PubMed ID: 35595173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal Trends in Clinician-Assessed and Patient-Reported Swallowing Outcomes in Oropharyngeal Cancer Patients.
    Kabalan S; Papadopoulos-Nydam G; Jeffery CC; Rieger J; Constantinescu G
    Am J Speech Lang Pathol; 2023 Mar; 32(2):492-505. PubMed ID: 36630888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translation and validation of the MD Anderson Dysphagia Inventory (MDADI) for Spanish-speaking patients.
    Montes-Jovellar L; Carrillo A; Muriel A; Barbera R; Sanchez F; Cobeta I
    Head Neck; 2019 Jan; 41(1):122-129. PubMed ID: 30549341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between swallow-specific quality of life and fiber-optic endoscopic evaluation of swallowing findings in patients with head and neck cancer.
    Florie M; Baijens L; Kremer B; Kross K; Lacko M; Verhees F; Winkens B
    Head Neck; 2016 Apr; 38 Suppl 1():E1848-56. PubMed ID: 26695518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Evaluation of Head and Neck Cancer Treatment-Related Dysphagia in the Development of a Personalized Treatment Deintensification Paradigm.
    Quon H; Hui X; Cheng Z; Robertson S; Peng L; Bowers M; Moore J; Choflet A; Thompson A; Muse M; Kiess A; Page B; Fakhry C; Gourin C; O'Hare J; Graham P; Szczesniak M; Maclean J; Cook I; McNutt T
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1271-1278. PubMed ID: 29165287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma.
    Hutcheson KA; Abualsamh AR; Sosa A; Weber RS; Beadle BM; Sturgis EM; Lewin JS
    Head Neck; 2016 Jun; 38(6):886-93. PubMed ID: 26339764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.